The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...
The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss drugs such as semaglutide (Ozempic or Wegovy), has been censured by the UK’s Prescription Medicines Code of Practice ...
A new study found that patients taking GLP-1s to treat type 2 diabetes have a lower risk of developing Alzheimer’s disease, potentially opening the door … ...
Den svenska pensionsjätten Alecta dumpade lejonparten av sitt innehav i den danska läkemedelsgiganten Novo Nordisk före den sensationella kraschen i december. Hittills har pensionsjätten realiserat ...
Novo Nordisk has announced topline results from the phase 3b trial STEP UP, which investigated the effects of two doses of Wegovy (semaglutide) in over 1,400 patients over the course of 72 weeks. Both ...
On Tuesday, BofA Securities expressed continued confidence in Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), maintaining a Buy rating and a price target of DKK1,075.00. The endorsement comes amidst ...
Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...
Kursen vänder sig till studenter som vill fördjupa sina kunskaper om Sveriges och de nordiska ländernas historia. Vi belyser regionens sociala och ekonomiska utveckling samt analyserar och ...
Volvo Cars batteribolag Novo Energy varslar omkring 120 anställda, rapporterar Sveriges Radio. Det motsvarar 30 procent av företagets personalstyrka. Anledningen till varslet är att Göteborgsbolaget ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback